67
Views
15
CrossRef citations to date
0
Altmetric
Perspective

Headache in the world: public health and research priorities

Pages 51-57 | Published online: 09 Jan 2014

References

  • Stovner Lj, Hagen K, Jensen R et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3), 193–210 (2007).
  • World Health Organization. Lifting The Burden. Atlas of Headache Disorders and Resources in the World 2011. WHO, Geneva, Switzerland (2011).
  • Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ. The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J. Headache Pain 12(3), 273–274 (2011).
  • International Headache Society Classification Subcommittee. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 24(Suppl. 1), 9–160 (2004).
  • Olesen J, Bousser MG, Diener HC et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26, 742–746 (2006).
  • Natoli JL, Manack A, Dean B et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 30(5), 599–609 (2010).
  • Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 3(8), 475–483 (2004).
  • World Health Organization. World Health Report 2001. WHO, Geneva, Switzerland (2001).
  • Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ. Lifting the burden: the first 7 years. J. Headache Pain 11(6), 451–455 (2010).
  • Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23(7), 519–527 (2003).
  • Rasmussen BK. Epidemiology of headache. Cephalalgia 15(1), 45–68 (1995).
  • Srikiatkhachorn A, Phanthumchinda K. Prevalence and clinical features of chronic daily headache in a headache clinic. Headache 37(5), 277–280 (1997).
  • Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39(3), 190–196 (1999).
  • Schürks M, Rist PM, Shapiro RE, Kurth T. Migraine and mortality: a systematic review and meta-analysis. Cephalalgia 31(12), 1301–1314 (2011).
  • Steiner TJ. Headache burdens and bearers. Funct. Neurol. 15(Suppl. 3), 219–223 (2000).
  • Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41(7), 638–645 (2001).
  • Steiner T, Lange R, Voelker M. Episodic tension-type headache (ETTH): evidence of prolonged disability from a placebo-controlled comparison of aspirin and paracetamol. Cephalalgia 23, 630 (2003).
  • Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 23(6), 429–440 (2003).
  • Linde M, Gustavsson A, Stovner LJ et al. The cost of headache disorders in Europe: the Eurolight project. Eur. J. Neurol. 19(5), 703–711 (2012).
  • Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J. Occup. Environ. Med. 39(4), 320–327 (1997).
  • Hopkins A, Menken M, DeFriese G. A record of patient encounters in neurological practice in the United Kingdom. J. Neurol. Neurosurg. Psychiatr. 52(4), 436–438 (1989).
  • Wiles CM, Lindsay M. General practice referrals to a department of neurology. J. R. Coll. Physicians Lond. 30(5), 426–431 (1996).
  • American Association for the Study of Headache, International Headache Society. Consensus statement on improving migraine management. Headache 38, 736 (1998).
  • Lipton RB, Scher AI, Steiner TJ et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 60(3), 441–448 (2003).
  • Dowson A, Jagger S. The UK migraine patient survey: quality of life and treatment. Curr. Med. Res. Opin. 15(4), 241–253 (1999).
  • Takeshima T, Ishizaki K, Fukuhara Y et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44(1), 8–19 (2004).
  • Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J. Epidemiol. Community Health 46(4), 443–446 (1992).
  • Steiner TJ, Antonaci F, Jensen R, Lainez MJ, Lanteri-Minet M, Valade D; European Headache Federation; Global Campaign against Headache. Recommendations for headache service organisation and delivery in Europe. J. Headache Pain 12(4), 419–426 (2011).
  • Coulter A. Shifting the balance from secondary to primary care. BMJ 311(7018), 1447–1448 (1995).
  • Hossain M. The provision of secondary care services in primary care (Diploma dissertation). Imperial College London, London, UK (1998).
  • Mateen F, Dua T, Steiner T, Saxena S. Research in low and middle income countries on the primary headache disorders over the past decade. Cephalalgia 27, 672 (2007).
  • United Nations Development Program. 1992 Human Development Report. Oxford University Press, NY, USA (1992).
  • Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 58(6), 885–894 (2002).
  • Bigal ME, Kolodner KB, Lafata JE, Leotta C, Lipton RB. Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan. Cephalalgia 26(1), 43–49 (2006).
  • Lohman JJHM, van der Kuy-de Ree MM. Patterns of specific antimigraine drug use – a study based on the records of 18 community pharmacies. Cephalalgia 25, 214–218 (2004).
  • Steiner TJ. Lifting The Burden: the global campaign to reduce the burden of headache worldwide. J. Headache Pain 6(5), 373–377 (2005).
  • International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia 11, 1–12 (1991).
  • International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 20, 765–786 (2000).
  • Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 18(1), 52–56 (1998).
  • Katsarava Z, Dzagnidze A, Kukava M et al.; Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide and the Russian Linguistic Subcommittee of the International Headache Society. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology 73(21), 1796–1803 (2009).
  • Yu S, Liu R, Zhao G et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52(4), 582–591 (2012).
  • Ayzenberg I, Katsarava Z, Sborowski A et al. Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32(5), 373–381 (2012).
  • Steiner TJ. Please don’t hijack ‘quality of life’. Cephalalgia 18, 227 (1998).
  • Peters M, Perera S, Loder E et al. Quality in the provision of headache care. 1: systematic review of the literature and commentary. J. Headache Pain 13(6), 437–447 (2012).
  • Peters M, Jenkinson C, Perera S et al. Quality in the provision of headache care. 2: defining quality and its indicators. J. Headache Pain 13(6), 449–457 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.